Fixing Healthcare Bottlenecks from First Principles: Interview with Enspectra Health CEO Gabriel Sanchez
Gabriel Sanchez, co-founder and CEO of Enspectra Health, earned his bachelor’s degree from MIT and his master’s and PhD in mechanical engineering from Stanford. With his graduate studies on neurodegenerative diseases, Gabriel’s plan was to become a professor. He served... Read More →
Fluid Biomed Inc. Raises $27 Million USD in Oversubscribed Series A Financing to Advance World’s First Bioabsorbable Polymer-Based Stent To Treat Brain Aneurysms
Funding co-led by Amplitude Ventures and an undisclosed major strategic investor to advance the ReSolv™ stent into additional human clinical trials CALGARY, Alberta–(BUSINESS WIRE)–Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular... Read More →
First Look: Flow Medical’s next-generation thrombolysis catheter for pulmonary embolism
Flow Medical is developing a thrombolysis catheter to improve the treatment of blood clots in pulmonary embolism patients. The Chicago-based startup designed its minimally invasive system with a novel nitinol scaffold that perforates blood clots and infuses them with tissue... Read More →
Execution Beats Flashy Funding: Interview with AccurKardia CEO Juan C. Jimenez
Juan C. Jimenez began his career in finance and investment banking, specializing in M&A transactions at Credit Suisse. After the 2008-2009 financial crisis, he pivoted to real estate distressed credit investment, which led him to a surprising role as President... Read More →
Infosys Backs Oncology-Focussed Healthtech Startup 4baseCare
IT giant Infosys is investing INR 8.3 Cr (nearly $1 Mn) to acquire a minority stake in healthtech startup 4baseCare. Infosys, in an exchange filing, said that the transaction will be executed via its venture capital arm, Infosys Innovation Fund.... Read More →
Liquet™ Medical Inc. Receives FDA 510(k) Clearance for the Versus™ Catheter: Hemodynamics-Led Thrombolysis (HLT) allows Physicians to Personalize the Treatment of Blood Clots in the Lungs utilizing Real-Time Pulmonary Artery Pressure.
Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Versus™ Catheter. This innovative medical device is... Read More →
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
(Patients with disseminated metastatic disease from breast cancer are likely to have liver involvement in >50% of cases at some point during disease progression.) Zetagen identifies two concentrations of Zeta-MBC-005 which were most effective in treating metastatic breast cancer in... Read More →
NVIDIA acquires VinBrain
Chief executive officer of American technology giant NVIDIA Jensen Huang said the company has acquired VinBrain, a start-up under Vingroup that offers medical products that use artificial intelligence (AI). The acquisition took place after NVIDIA signed an agreement with the... Read More →
New Investment from FBomb Angels featuring Opticyte
Thank you to the FBomb Angels for a meaningful investment that supports our mission to transform health equity and sepsis detection through our VitalO₂ monitor. We are the health equity change we want to see in the world. This new... Read More →
Demonstrating commitment to continuous portfolio innovation, Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Guidewire Handle and launches its latest software advancements
CLEVELAND, Dec. 4, 2024 /PRNewswire/ — Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced that the company has received US Food and Drug Administration (FDA) 510(k) clearance for its new IOPS Guidewire Handle. This... Read More →